"Drostanolone propionate"

English 2 alpha-methyldihydrotestosterone propionate, drostanolone propionate, Dromostanolone Propionate, 2 Alpha-Methyldihydrotestosterone Propionate, 2-Alpha-Methyldihydrotestosterone Propionate, dromostanolone propionate, 2.alpha.-Methyldihydrotestosterone propionate, DROMOSTANOLONE PROPIONATE, Drostanolone propionate, Drostanolone propionate (product), DSP, Drostanolone Propionate , Emdisterone, Drostanolone propionate (substance) Spanish propionato de drostanolona (producto), propionato de drostanolona, propionato de drostanolona (sustancia

English 2 alpha-methyldihydrotestosterone propionate, drostanolone propionate, Dromostanolone Propionate, 2 Alpha-Methyldihydrotestosterone Propionate, 2-Alpha-Methyldihydrotestosterone Propionate, dromostanolone propionate, 2.alpha.-Methyldihydrotestosterone propionate, DROMOSTANOLONE PROPIONATE, Drostanolone propionate, Drostanolone propionate (product), DSP, Drostanolone Propionate , Emdisterone, Drostanolone propionate (substance) Spanish propionato de drostanolona (producto), propionato de drostanolona, propionato de drostanolona (sustancia

Hormonal therapy of breast cancer with special reference to Masteril therapy. From 1968 to 1972, a trial of a new agent, drostanolone propionate (Masteril), was conducted. This agent was tested against oophorectomy in a group of premenopausal patients, against nandrolone phenylpropionate (Durabolin) in a perimenopausal group, and against ethinyl oestradiol in a postmenopausal group

[Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both]. A randomized trial was done in 98 post-menopausal women with breast cancer. Hormonal receptors had not been assayed in any patient. Patients were given hormonal therapy with tamoxifen and drostanolone propionate (n = 34), or chemotherapy with the CMF

A comparison of drostanolone propionate (Masteril) and nandrolone decanoate (Deca-durabolin) in the treatment of breast carcinoma.

of a tumor-promoting hormone called insulin-like growth factor-1 (IGF1).[27][unreliable medical source?] * Anabolic steroids such as testosterone, fluoxymesterone, drostanolone propionate, epitiostanol, and mepitiostane have historically been used to treat breast cancer because of their antiestrogenic effects in the breasts but are now rarely if ever used due to their virilizing side effects.[28]Route/form Androstanolone (DHT) Aqueous suspension 300 mg 3x/week Drostanolone propionate Oil solution 100 mg 1–3x/week Metenolone enanthate Oil solution 400 mg 3x/week Nandrolone decanoate

* Drostanolone * Drostanolone propionate

mg/day Drostanolone propionate Injection 100 mg 3 times/week Ethylestrenol Oral 2–8 mg/day Fluoxymesterone Oral 2–40 mg/day Mesterolone include methyltestosterone, oxandrolone, mesterolone, and oxymetholone, as well as drostanolone propionate (dromostanolone propionate), metenolone (methylandrostenolone) esters (specifically metenolone acetate and metenolone enanthate), and fluoxymesterone.[1] Dihydrotestosterone (DHT), known as androstanolone or stanolone when used medically, and its esters are also notable, although

* Bolazine capronate * Drostanolone propionate (dromostanolone